GT Tucker

4.3k total citations · 2 hit papers
88 papers, 3.3k citations indexed

About

GT Tucker is a scholar working on Pharmacology, Spectroscopy and Pharmacology. According to data from OpenAlex, GT Tucker has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pharmacology, 15 papers in Spectroscopy and 14 papers in Pharmacology. Recurrent topics in GT Tucker's work include Pharmacogenetics and Drug Metabolism (32 papers), Analytical Chemistry and Chromatography (15 papers) and Analytical Methods in Pharmaceuticals (12 papers). GT Tucker is often cited by papers focused on Pharmacogenetics and Drug Metabolism (32 papers), Analytical Chemistry and Chromatography (15 papers) and Analytical Methods in Pharmaceuticals (12 papers). GT Tucker collaborates with scholars based in United Kingdom, Mexico and India. GT Tucker's co-authors include MS Lennard, M. S. Lennard, HF Woods, H.K. Crewe, R. E. Haddock, A H Beckett, Clare E. Casey, PJ Phillips, Henry Connor and Ward Jd and has published in prestigious journals such as Journal of Controlled Release, Journal of Pharmacology and Experimental Therapeutics and Journal of Chromatography A.

In The Last Decade

GT Tucker

88 papers receiving 3.1k citations

Hit Papers

Metformin kinetics in healthy subjects and in patients wi... 1981 2026 1996 2011 1981 1992 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
GT Tucker United Kingdom 27 1.4k 715 675 648 451 88 3.3k
Christer von Bahr Sweden 31 1.3k 0.9× 520 0.7× 496 0.7× 811 1.3× 340 0.8× 104 3.5k
Harold Boxenbaum United States 28 1.0k 0.7× 707 1.0× 644 1.0× 748 1.2× 293 0.6× 73 3.7k
M. S. Lennard United Kingdom 36 2.4k 1.7× 1.1k 1.5× 847 1.3× 774 1.2× 727 1.6× 114 4.6k
Felix Bochner Australia 42 1.3k 0.9× 826 1.2× 1.2k 1.8× 710 1.1× 423 0.9× 162 5.3k
Gunnel Tybring Sweden 40 2.0k 1.4× 929 1.3× 765 1.1× 662 1.0× 261 0.6× 73 4.2k
T. Inaba Canada 37 2.7k 1.9× 1.3k 1.8× 899 1.3× 1.0k 1.6× 456 1.0× 122 5.2k
Jacques Turgeon Canada 42 1.5k 1.1× 624 0.9× 703 1.0× 1.2k 1.9× 371 0.8× 187 4.8k
Roger K. Verbeeck Belgium 36 1.4k 1.0× 817 1.1× 1.2k 1.8× 647 1.0× 207 0.5× 156 4.7k
Ingolf Meineke Germany 32 1.2k 0.9× 957 1.3× 614 0.9× 781 1.2× 155 0.3× 89 3.6k
Allen J. Sedman United States 32 531 0.4× 420 0.6× 661 1.0× 603 0.9× 307 0.7× 86 3.2k

Countries citing papers authored by GT Tucker

Since Specialization
Citations

This map shows the geographic impact of GT Tucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GT Tucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GT Tucker more than expected).

Fields of papers citing papers by GT Tucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GT Tucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GT Tucker. The network helps show where GT Tucker may publish in the future.

Co-authorship network of co-authors of GT Tucker

This figure shows the co-authorship network connecting the top 25 collaborators of GT Tucker. A scholar is included among the top collaborators of GT Tucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GT Tucker. GT Tucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rostami‐Hodjegan, Amin, et al.. (2002). Analysis of Solvent Central Nervous System Toxicity and Ethanol Interactions Using a Human Population Physiologically Based Kinetic and Dynamic Model. Regulatory Toxicology and Pharmacology. 35(2). 165–176. 15 indexed citations
3.
Tucker, GT. (2001). Optimizing drug development: Strategies to assess drug metabolism/transporter interaction potential-toward a consensus. Clinical Pharmacology & Therapeutics. 70(2). 103–114. 109 indexed citations
4.
Marsh, J. C. W., Joanna Chowdry, Nilima Parry‐Jones, et al.. (1999). Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia. British Journal of Haematology. 104(2). 266–270. 21 indexed citations
5.
Segall, Matthew, M. C. Payne, S. W. Ellis, GT Tucker, & Peter Eddershaw. (1999). First principles investigation of singly reduced cytochrome P450. Xenobiotica. 29(6). 561–571. 8 indexed citations
6.
Rostami‐Hodjegan, Amin, et al.. (1996). Caffeine urinary metabolite ratios as markers of enzyme activity: a theoretical assessment. Pharmacogenetics. 6(2). 121–149. 100 indexed citations
7.
Williams, Mary L., M. S. Lennard, Iain Martin, & GT Tucker. (1994). Interindividual variation in the isomerization of 4- hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450. Carcinogenesis. 15(12). 2733–2738. 38 indexed citations
8.
Henderson, Colin J., et al.. (1992). Delineation of human cytochromes P450 involved in the metabolism of tamoxifen. British Journal of Clinical Pharmacology. 34(2). 8 indexed citations
9.
Lennard, M. S., et al.. (1991). Effect of steroids on the cytochrome P4502D6-catalysed metabolism of metoprolol. Pharmacogenetics. 1(2). 119–122. 7 indexed citations
10.
Tucker, GT & M. S. Lennard. (1990). Enantiomer specific pharmacokinetics. Pharmacology & Therapeutics. 45(3). 309–329. 169 indexed citations
11.
Tucker, GT, et al.. (1990). PLASMA CONCENTRATIONS OF THE STEREOISOMERS OF PRILOCAINE AFTER ADMINISTRATION OF THE RACEMATE: IMPLICATIONS FOR TOXICITY? †. British Journal of Anaesthesia. 65(3). 333–336. 15 indexed citations
12.
Ching, Michael S., et al.. (1989). Measurement of underivatised metoprolol enantiomers in human plasma by high-performance liquid chromatography with a chiral stationary phase. Journal of Chromatography B Biomedical Sciences and Applications. 497. 313–318. 24 indexed citations
13.
Lennard, M. S., et al.. (1989). Inhibition of lignocaine metabolism by β-adrenoceptor antagonists in rat and human liver microsomes. Xenobiotica. 19(9). 929–944. 11 indexed citations
14.
Otton, S V, H.K. Crewe, M. S. Lennard, GT Tucker, & H. F. Woods. (1988). Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 242–247. 142 indexed citations
15.
Waller, P.J., GT Tucker, & LE Ramsay. (1987). Lack of effect of ketanserin on indices of hepatic enzyme induction.. British Journal of Clinical Pharmacology. 24(1). 118–119. 2 indexed citations
16.
Tucker, GT, et al.. (1984). Protecting the poor metaboliser—from Jack & Wilkins. Dr Lennard et al. reply as follows. British Journal of Clinical Pharmacology. 17(4). 489–492. 5 indexed citations
17.
Silas, JH, MS Lennard, GT Tucker, LE Ramsay, & HF Woods. (1984). Polymorphic metabolism of beta‐adrenoceptor antagonists.. British Journal of Clinical Pharmacology. 17(S1). 11S–19S. 15 indexed citations
18.
Tucker, GT, et al.. (1984). Effects of beta‐adrenoceptor antagonists on the pharmacokinetics of lignocaine.. British Journal of Clinical Pharmacology. 17(S1). 21S–28S. 27 indexed citations
19.
Ramsay, L E & GT Tucker. (1981). Clinical pharmacology: drugs and the elderly.. BMJ. 282(6258). 125–127. 32 indexed citations
20.
Tucker, GT. (1981). Measurement of the renal clearance of drugs.. British Journal of Clinical Pharmacology. 12(6). 761–770. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026